id	sid	eid	entity	type
globalce-210	1	1	11	CARDINAL
globalce-210	1	2	2	CARDINAL
globalce-210	1	3	2025	CARDINAL
globalce-210	1	4	july 31	DATE
globalce-210	1	5	2024	DATE
globalce-210	1	6	march 4, 2025,	DATE
globalce-210	1	7	april 11 2025	DATE
globalce-210	2	1	ema	ORG
globalce-210	2	2	fda	ORG
globalce-210	2	3	gaur1	ORG
globalce-210	2	4	akram1	ORG
globalce-210	2	5	singh2	ORG
globalce-210	2	6	chauhan3	PERSON
globalce-210	2	7	1	CARDINAL
globalce-210	2	8	up-201301, india	ORG
globalce-210	2	9	2	CARDINAL
globalce-210	2	10	up-201301, india	ORG
globalce-210	2	11	3	CARDINAL
globalce-210	2	12	up-201301, india	ORG
globalce-210	7	1	the european union	ORG
globalce-210	7	2	eu	ORG
globalce-210	7	3	the united states	GPE
globalce-210	7	4	fda	ORG
globalce-210	7	5	india	GPE
globalce-210	7	6	india	GPE
globalce-210	7	7	cdsco	PERSON
globalce-210	8	1	eu	ORG
globalce-210	8	2	the european medicines	ORG
globalce-210	8	3	ema	ORG
globalce-210	8	4	fda	ORG
globalce-210	8	5	the united states	GPE
globalce-210	10	1	india	GPE
globalce-210	13	1	2025	DATE
globalce-210	14	1	4.0	CARDINAL
globalce-210	14	2	4.0	CARDINAL
globalce-210	17	1	akram	GPE
globalce-210	17	2	singh	GPE
globalce-210	17	3	ema	ORG
globalce-210	17	4	fda	ORG
globalce-210	17	5	2	CARDINAL
globalce-210	17	6	2025	CARDINAL
globalce-210	17	7	12	CARDINAL
globalce-210	17	8	datadriven	ORG
globalce-210	18	1	the european union	ORG
globalce-210	18	2	eu	ORG
globalce-210	18	3	fda	ORG
globalce-210	18	4	india	GPE
globalce-210	20	1	gmlp	PERSON
globalce-210	22	1	fda	ORG
globalce-210	27	1	1	CARDINAL
globalce-210	28	1	1	CARDINAL
globalce-210	36	1	13	CARDINAL
globalce-210	36	2	2	CARDINAL
globalce-210	36	3	2025	CARDINAL
globalce-210	36	4	akram	GPE
globalce-210	36	5	singh	GPE
globalce-210	36	6	ema	ORG
globalce-210	36	7	fda	ORG
globalce-210	41	1	ecg	ORG
globalce-210	52	1	fda	ORG
globalce-210	52	2	united states	GPE
globalce-210	52	3	uk	GPE
globalce-210	52	4	canada	GPE
globalce-210	53	1	saudi arabia	GPE
globalce-210	54	1	constraints.10 gaur	GPE
globalce-210	54	2	akram	GPE
globalce-210	54	3	singh	GPE
globalce-210	54	4	ema	ORG
globalce-210	54	5	fda	ORG
globalce-210	54	6	2	CARDINAL
globalce-210	54	7	2025 14	DATE
globalce-210	55	1	ema	ORG
globalce-210	55	2	ema	ORG
globalce-210	55	3	ema	ORG
globalce-210	55	4	ema	ORG
globalce-210	56	1	ema	ORG
globalce-210	56	2	eu	ORG
globalce-210	58	1	ema.17	ORG
globalce-210	58	2	ema	ORG
globalce-210	58	3	ema	ORG
globalce-210	59	1	ema	ORG
globalce-210	59	2	the european medicines	ORG
globalce-210	59	3	ema	ORG
globalce-210	59	4	ema	ORG
globalce-210	59	5	eu	ORG
globalce-210	59	6	the united states	GPE
globalce-210	59	7	india	GPE
globalce-210	60	1	eu	ORG
globalce-210	60	2	the united states	GPE
globalce-210	61	1	india	GPE
globalce-210	61	2	european	NORP
globalce-210	61	3	eu	ORG
globalce-210	63	1	the european medicines	ORG
globalce-210	63	2	ema	ORG
globalce-210	63	3	ema	ORG
globalce-210	64	1	mdcg	GPE
globalce-210	64	2	ema	ORG
globalce-210	65	1	15	CARDINAL
globalce-210	65	2	2	CARDINAL
globalce-210	65	3	2025	CARDINAL
globalce-210	65	4	akram	GPE
globalce-210	65	5	singh	GPE
globalce-210	65	6	ema	ORG
globalce-210	65	7	fda	ORG
globalce-210	66	1	ema	ORG
globalce-210	66	2	discovery	PRODUCT
globalce-210	68	1	ema	ORG
globalce-210	70	1	ema	ORG
globalce-210	70	2	december 31	DATE
globalce-210	70	3	2023.22	CARDINAL
globalce-210	70	4	food and drug	ORG
globalce-210	70	5	fda	ORG
globalce-210	71	1	fda	ORG
globalce-210	73	1	transparency.24 fda	PERSON
globalce-210	73	2	fda	ORG
globalce-210	73	3	fda	ORG
globalce-210	75	1	fda	ORG
globalce-210	76	1	fda	ORG
globalce-210	78	1	fda	ORG
globalce-210	78	2	april 2019	DATE
globalce-210	79	1	january 2021	DATE
globalce-210	79	2	fda	ORG
globalce-210	79	3	samd.27	GPE
globalce-210	79	4	october 2021	DATE
globalce-210	80	1	april 2023	DATE
globalce-210	81	1	october 2023	DATE
globalce-210	82	1	june 2024	DATE
globalce-210	82	2	akram	GPE
globalce-210	82	3	singh	GPE
globalce-210	82	4	ema	ORG
globalce-210	82	5	fda	ORG
globalce-210	82	6	2	CARDINAL
globalce-210	82	7	2025	CARDINAL
globalce-210	82	8	16	CARDINAL
globalce-210	83	1	29	CARDINAL
globalce-210	83	2	fda	ORG
globalce-210	83	3	fda	ORG
globalce-210	86	1	fda	ORG
globalce-210	86	2	up to	CARDINAL
globalce-210	86	3	2024 to approximately 64	DATE
globalce-210	87	1	fda	ORG
globalce-210	87	2	three	CARDINAL
globalce-210	90	1	fda	ORG
globalce-210	91	1	fda	ORG
globalce-210	91	2	gmlp	PERSON
globalce-210	95	1	fda	ORG
globalce-210	97	1	fda	ORG
globalce-210	98	1	two	CARDINAL
globalce-210	98	2	india	GPE
globalce-210	98	3	17	CARDINAL
globalce-210	98	4	2	CARDINAL
globalce-210	98	5	2025	CARDINAL
globalce-210	98	6	akram	GPE
globalce-210	98	7	singh	GPE
globalce-210	98	8	ema	ORG
globalce-210	98	9	fda	ORG
globalce-210	98	10	india	GPE
globalce-210	99	1	august 1, 2019	DATE
globalce-210	99	2	2017	CARDINAL
globalce-210	100	1	india	GPE
globalce-210	109	1	2020	DATE
globalce-210	110	1	india	GPE
globalce-210	110	2	2017	DATE
globalce-210	112	1	india	GPE
globalce-210	112	2	india	GPE
globalce-210	113	1	four	CARDINAL
globalce-210	114	1	ivd medical	ORG
globalce-210	115	1	india	GPE
globalce-210	115	2	ivd medical	ORG
globalce-210	117	1	gaur, akram	ORG
globalce-210	117	2	singh	GPE
globalce-210	117	3	ema	ORG
globalce-210	117	4	fda	ORG
globalce-210	117	5	2	CARDINAL
globalce-210	117	6	2025	CARDINAL
globalce-210	117	7	18	CARDINAL
globalce-210	117	8	1	CARDINAL
globalce-210	118	1	european	NORP
globalce-210	118	2	eu	ORG
globalce-210	118	3	united states	GPE
globalce-210	118	4	fda	ORG
globalce-210	118	5	india	GPE
globalce-210	119	1	eu	PERSON
globalce-210	121	1	510	CARDINAL
globalce-210	122	1	fda	ORG
globalce-210	133	1	regulators.46	ORG
globalce-210	133	2	challenges.47	ORG
globalce-210	133	3	19	CARDINAL
globalce-210	133	4	2	CARDINAL
globalce-210	133	5	2025	CARDINAL
globalce-210	133	6	akram	GPE
globalce-210	133	7	singh	GPE
globalce-210	133	8	ema	ORG
globalce-210	133	9	fda	ORG
globalce-210	133	10	india	GPE
globalce-210	133	11	iec 62304	ORG
globalce-210	133	12	iec 60601-1	ORG
globalce-210	133	13	iec 82304-1	ORG
globalce-210	133	14	1	CARDINAL
globalce-210	135	1	ema	ORG
globalce-210	135	2	fda	ORG
globalce-210	135	3	cdsco	PERSON
globalce-210	142	1	one	CARDINAL
globalce-210	145	1	seven	CARDINAL
globalce-210	147	1	medtech innovation.49	ORG
globalce-210	147	2	ema	ORG
globalce-210	147	3	fda	ORG
globalce-210	149	1	ema	ORG
globalce-210	149	2	fda	ORG
globalce-210	150	1	india	GPE
globalce-210	151	1	fda	ORG
globalce-210	152	1	ema	ORG
globalce-210	153	1	india	GPE
globalce-210	153	2	akram	GPE
globalce-210	153	3	singh	GPE
globalce-210	153	4	ema	ORG
globalce-210	153	5	fda	ORG
globalce-210	153	6	2	CARDINAL
globalce-210	153	7	2025 20	CARDINAL
globalce-210	155	1	fda	ORG
globalce-210	159	1	standards.49	ORG
globalce-210	161	1	one	CARDINAL
globalce-210	162	1	xai	ORG
globalce-210	165	1	fda	ORG
globalce-210	166	1	fda	ORG
globalce-210	167	1	ema	ORG
globalce-210	167	2	cdsco	PERSON
globalce-210	168	1	fda	ORG
globalce-210	169	1	fda	ORG
globalce-210	170	1	ema	ORG
globalce-210	170	2	cdsco	PERSON
globalce-210	170	3	one	CARDINAL
globalce-210	171	1	one	CARDINAL
globalce-210	171	2	one	CARDINAL
globalce-210	176	1	one	CARDINAL
globalce-210	176	2	one	CARDINAL
globalce-210	176	3	21	CARDINAL
globalce-210	176	4	2	CARDINAL
globalce-210	176	5	2025	CARDINAL
globalce-210	176	6	akram	GPE
globalce-210	176	7	singh	GPE
globalce-210	176	8	ema	ORG
globalce-210	176	9	fda	ORG
globalce-210	177	1	ema	ORG
globalce-210	177	2	fda	ORG
globalce-210	179	1	ema	ORG
globalce-210	182	1	ema	ORG
globalce-210	183	1	eu	ORG
globalce-210	184	1	ema	ORG
globalce-210	186	1	fda	ORG
globalce-210	188	1	fda	ORG
globalce-210	192	1	indian	NORP
globalce-210	192	2	iec 62304	ORG
globalce-210	192	3	iec 60601-1	ORG
globalce-210	192	4	iec 82304-1	ORG
globalce-210	196	1	r.g.	GPE
globalce-210	197	1	i.s.	GPE
globalce-210	197	2	i.s.	GPE
globalce-210	197	3	i.s.	GPE
globalce-210	197	4	a.a.	GPE
globalce-210	197	5	r.g.	GPE
globalce-210	197	6	a.a.	GPE
globalce-210	198	1	i.s.	GPE
globalce-210	198	2	i.s.	PERSON
globalce-210	199	1	amity university noida	ORG
globalce-210	203	1	gaur, akram	ORG
globalce-210	203	2	singh	GPE
globalce-210	203	3	ema	ORG
globalce-210	203	4	fda	ORG
globalce-210	203	5	2	CARDINAL
globalce-210	203	6	2025	CARDINAL
globalce-210	203	7	22	CARDINAL
globalce-210	206	1	1	CARDINAL
globalce-210	210	1	2	CARDINAL
globalce-210	210	2	food and drug administration	ORG
globalce-210	210	3	fda	ORG
globalce-210	213	1	https://www.fda	PERSON
globalce-210	215	1	3	CARDINAL
globalce-210	215	2	shick	ORG
globalce-210	215	3	a.a.	GPE
globalce-210	215	4	webber	PERSON
globalce-210	215	5	c.m.	GPE
globalce-210	215	6	kiarashi	ORG
globalce-210	217	1	2024;7(1):21	CARDINAL
globalce-210	219	1	4	CARDINAL
globalce-210	219	2	parenteral drug association	ORG
globalce-210	221	1	www.pda.org/pda-letter-portal/home/full-article/acomprehensive-review-of-regulatory-intelligenceexploring-tools-and-program-maturities.	CARDINAL
globalce-210	222	1	koli	PERSON
globalce-210	222	2	raut	PERSON
globalce-210	222	3	s.	GPE
globalce-210	222	4	mande	GPE
globalce-210	222	5	r.	NORP
globalce-210	225	1	2023;11(4):b953	CARDINAL
globalce-210	227	1	php?&p_id=ijcrt2304232	PERSON
globalce-210	228	1	6	CARDINAL
globalce-210	228	2	zhou	PERSON
globalce-210	228	3	k.	PERSON
globalce-210	228	4	gattinger	PERSON
globalce-210	228	5	today	DATE
globalce-210	229	1	innov regul sci	PERSON
globalce-210	231	1	https://doi.org/10.1007/ s43441-024-00628-3	PERSON
globalce-210	231	2	7	CARDINAL
globalce-210	231	3	wenzel	PERSON
globalce-210	232	1	2020;4(3):64–69	CARDINAL
globalce-210	233	1	8	CARDINAL
globalce-210	234	1	rajkomar, a.	PERSON
globalce-210	234	2	dean	PERSON
globalce-210	234	3	j.	PERSON
globalce-210	234	4	kohane	PERSON
globalce-210	234	5	i.	PERSON
globalce-210	236	1	2019;380(14):1347–1358	CARDINAL
globalce-210	237	1	https://doi.org/10.1056/nejmra1814259	PERSON
globalce-210	238	1	wenzel	GPE
globalce-210	238	2	m.a.	GPE
globalce-210	239	1	2019	DATE
globalce-210	239	2	itu kaleidoscope	PERSON
globalce-210	239	3	itu k	PERSON
globalce-210	239	4	atlanta	GPE
globalce-210	239	5	ga, usa	ORG
globalce-210	239	6	december 2019	DATE
globalce-210	239	7	xplore	CARDINAL
globalce-210	239	8	piscateville	ORG
globalce-210	239	9	new jersey	GPE
globalce-210	239	10	10	CARDINAL
globalce-210	239	11	european	NORP
globalce-210	240	1	eu	PERSON
globalce-210	240	2	first	ORDINAL
globalce-210	240	3	2013	DATE
globalce-210	242	1	first	ORDINAL
globalce-210	243	1	11	CARDINAL
globalce-210	244	1	european medicines	ORG
globalce-210	244	2	ema	ORG
globalce-210	247	1	12	CARDINAL
globalce-210	247	2	muehlematter	ORG
globalce-210	247	3	u.j.	GPE
globalce-210	247	4	daniore	ORG
globalce-210	247	5	k.n.	GPE
globalce-210	247	6	the usa and europe	ORG
globalce-210	247	7	2015–20	ORDINAL
globalce-210	248	1	lancet	ORG
globalce-210	249	1	2021;3(3):e195	CARDINAL
globalce-210	251	1	k.	PERSON
globalce-210	254	1	berlin	GPE
globalce-210	254	2	germany	GPE
globalce-210	254	3	2024	DATE
globalce-210	255	1	67–115	DATE
globalce-210	256	1	14	DATE
globalce-210	258	1	15	CARDINAL
globalce-210	259	1	eu	PERSON
globalce-210	263	1	16	CARDINAL
globalce-210	264	1	european medicines	ORG
globalce-210	267	1	17	CARDINAL
globalce-210	268	1	eu ema	PERSON
globalce-210	269	1	aspx?g=2debbf90-5595-412d-b05d-744a5f116c27	LAW
globalce-210	271	1	https://doi.org/10.1056/nejmra1814259	PERSON
globalce-210	272	1	https://www.europarl.europa.eu/topics/en/article/20230601sto93804/eu-ai-act-first-regulation-on-artificial-intelligence https://www.europarl.europa.eu/topics/en/article/20230601sto93804/eu-ai-act-first-regulation-on-artificial-intelligence https://www.europarl.europa.eu/topics/en/article/20230601sto93804/eu-ai-act-first-regulation-on-artificial-intelligence https://www.ema.europa.eu/en/news/artificial-intelligence-workplan-guide-use-ai-medicines-regulation https://www.ema.europa.eu/en/news/artificial-intelligence-workplan-guide-use-ai-medicines-regulation	PERSON
globalce-210	272	2	https://doi.org/10.1016/s2589-7500(20)30292-2 https://doi.org/10.1007/978-981-97-2954-8_3 https://doi.org/10.1007/978-981-97-2954-8_3 https://doi.org/10.2139/ssrn.4679812 https://doi.org/10.2139/ssrn.4679812 https://www.sidley.com/en/insights/newsupdates/2023/12/eu-reach-political-agreement-on-ai-act	PRODUCT
globalce-210	272	3	23	CARDINAL
globalce-210	272	4	2	CARDINAL
globalce-210	272	5	2025	CARDINAL
globalce-210	272	6	akram	GPE
globalce-210	272	7	singh	GPE
globalce-210	272	8	ema	ORG
globalce-210	272	9	fda	ORG
globalce-210	272	10	18	CARDINAL
globalce-210	273	1	european medicines	ORG
globalce-210	273	2	ema	ORG
globalce-210	276	1	19	CARDINAL
globalce-210	276	2	european medicines	ORG
globalce-210	276	3	ema	ORG
globalce-210	281	1	20	CARDINAL
globalce-210	282	1	benjamens	GPE
globalce-210	282	2	s.	GPE
globalce-210	282	3	meskó	GPE
globalce-210	283	1	fda	ORG
globalce-210	285	1	2020;3:118	CARDINAL
globalce-210	286	1	020-00324	CARDINAL
globalce-210	286	2	21	CARDINAL
globalce-210	287	1	jain, a.	ORG
globalce-210	287	2	araveeti	PERSON
globalce-210	287	3	s.r.	GPE
globalce-210	287	4	fda	ORG
globalce-210	289	1	2024;13(3):498	CARDINAL
globalce-210	291	1	22	DATE
globalce-210	292	1	food and drug administration	ORG
globalce-210	292	2	fda	ORG
globalce-210	294	1	23	CARDINAL
globalce-210	295	1	food and drug administration	ORG
globalce-210	295	2	fda	ORG
globalce-210	297	1	https://www.fda.gov/regulatory-information/	PERSON
globalce-210	298	1	24	CARDINAL
globalce-210	298	2	food and drug administration	ORG
globalce-210	298	3	fda	ORG
globalce-210	299	1	fda	ORG
globalce-210	300	1	https://www.fda.gov/news-events/	ORG
globalce-210	300	2	fda	ORG
globalce-210	301	1	25	CARDINAL
globalce-210	301	2	food and drug administration	ORG
globalce-210	301	3	fda	ORG
globalce-210	302	1	fda	ORG
globalce-210	303	1	https://starfishmedical.com/blog/ fda-action	ORG
globalce-210	303	2	26	CARDINAL
globalce-210	305	1	fda	ORG
globalce-210	306	1	fda	ORG
globalce-210	307	1	27	CARDINAL
globalce-210	308	1	gilbert	PERSON
globalce-210	308	2	m.	PERSON
globalce-210	308	3	i.	PERSON
globalce-210	309	1	2021	CARDINAL
globalce-210	309	2	fda	ORG
globalce-210	314	1	28	CARDINAL
globalce-210	314	2	food and drug administration	ORG
globalce-210	314	3	fda	ORG
globalce-210	317	1	https://www.fda	PERSON
globalce-210	319	1	29	CARDINAL
globalce-210	319	2	ropes & gray	ORG
globalce-210	320	1	fda	ORG
globalce-210	322	1	30	CARDINAL
globalce-210	323	1	lecun	PERSON
globalce-210	323	2	bengio	GPE
globalce-210	323	3	hinton	PERSON
globalce-210	325	1	2015;521:436–444	CARDINAL
globalce-210	326	1	https://doi.org/10.1038/ nature14539	PERSON
globalce-210	328	1	s., babic	ORG
globalce-210	328	2	b.	PERSON
globalce-210	331	1	2020;3(1):53	CARDINAL
globalce-210	331	2	020	CARDINAL
globalce-210	332	1	https://doi.org/10.3390/electronics13030498 https://doi.org/10.3390/electronics13030498 https://www.fda.gov/files/medical%20devices/published/us-fda-artificial-intelligence-and-machine-learning-discussion-paper.pdf https://www.fda.gov/files/medical%20devices/published/us-fda-artificial-intelligence-and-machine-learning-discussion-paper.pdf https://www.fda.gov/files/medical%20devices/published/us-fda-artificial-intelligence-and-machine-learning-discussion-paper.pdf https://www.fda.gov/files/medical%20devices/published/us-fda-artificial-intelligence-and-machine-learning-discussion-paper.pdf	PERSON
globalce-210	332	2	https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan	PERSON
globalce-210	332	3	akram	GPE
globalce-210	332	4	singh	GPE
globalce-210	332	5	ema	ORG
globalce-210	332	6	fda	ORG
globalce-210	332	7	2	CARDINAL
globalce-210	332	8	2025	CARDINAL
globalce-210	332	9	24 32	DATE
globalce-210	333	1	bharadwaj	ORG
globalce-210	333	2	m.s.	GPE
globalce-210	334	1	chatterjee	GPE
globalce-210	334	2	l.	GPE
globalce-210	334	3	2024	DATE
globalce-210	335	1	33	CARDINAL
globalce-210	336	1	ddreg pharma	PERSON
globalce-210	338	1	ddregpharma.com/blogs/regulatory-guidelines-forsoftware-and-artificial-intelligence-as-a-medical-device/. 34	ORG
globalce-210	339	1	health services ministry of health	ORG
globalce-210	339	2	india	GPE
globalce-210	340	1	35	CARDINAL
globalce-210	341	1	freyr	ORG
globalce-210	342	1	india	GPE
globalce-210	344	1	36	CARDINAL
globalce-210	346	1	ivd medical devices	ORG
globalce-210	348	1	37	CARDINAL
globalce-210	351	1	https://www.imdrf.org/sites/default/	ORG
globalce-210	352	1	38	CARDINAL
globalce-210	354	1	ivd medical devices	ORG
globalce-210	358	1	39	CARDINAL
globalce-210	359	1	chen	PERSON
globalce-210	359	2	e.	GPE
globalce-210	359	3	banerjee	GPE
globalce-210	360	1	nat med.	PERSON
globalce-210	363	1	40	CARDINAL
globalce-210	364	1	us	GPE
globalce-210	364	2	eu	PERSON
globalce-210	366	1	41	CARDINAL
globalce-210	370	1	42	CARDINAL
globalce-210	370	2	d.	NORP
globalce-210	370	3	wachter	GPE
globalce-210	370	4	s.	PERSON
globalce-210	372	1	j law biosci	PERSON
globalce-210	375	1	43	DATE
globalce-210	376	1	raji	PERSON
globalce-210	376	2	i.d.	GPE
globalce-210	376	3	kumar	PERSON
globalce-210	376	4	horowitz, a.	PERSON
globalce-210	378	1	acm int conf proc	ORG
globalce-210	379	1	2022:959–972	TIME
globalce-210	379	2	june 21	DATE
globalce-210	382	1	matheny	PERSON
globalce-210	382	2	m.e.	GPE
globalce-210	382	3	d.	NORP
globalce-210	382	4	thadaney israni	PERSON
globalce-210	382	5	s.	PERSON
globalce-210	382	6	the national academy of medicine	ORG
globalce-210	384	1	2020;323(6):509–510	CARDINAL
globalce-210	386	1	45	DATE
globalce-210	386	2	khan	GPE
globalce-210	386	3	b.	PERSON
globalce-210	386	4	fatima	PERSON
globalce-210	386	5	h.	PERSON
globalce-210	386	6	qureshi, a.	ORG
globalce-210	387	1	2023;1:731–738	CARDINAL
globalce-210	388	1	46	DATE
globalce-210	389	1	henry	PERSON
globalce-210	389	2	thiel	GPE
globalce-210	390	1	technol	ORG
globalce-210	391	1	2022;56(4):114–118	CARDINAL
globalce-210	393	1	47	DATE
globalce-210	394	1	palaniappan, k., lin, e.y.t	PERSON
globalce-210	394	2	vogel	ORG
globalce-210	394	3	s. global	PERSON
globalce-210	395	1	healthcare	ORG
globalce-210	398	1	48	DATE
globalce-210	399	1	2022	CARDINAL
globalce-210	399	2	september 26	DATE
globalce-210	400	1	digital health software precertification	ORG
globalce-210	401	1	u.s.	GPE
globalce-210	401	2	food and drug administration	ORG
globalce-210	403	1	https://www.fda	PERSON
globalce-210	405	1	49	CARDINAL
globalce-210	406	1	s., minssen	ORG
globalce-210	406	2	t.,	GPE
globalce-210	406	3	cohen	PERSON
globalce-210	406	4	g. ethical	PERSON
globalce-210	407	1	1st	ORDINAL
globalce-210	407	2	bohr, a. and memarzadeh	ORG
globalce-210	407	3	k.	PERSON
globalce-210	409	1	https://resource.ddregpharma.com/blogs/regulatory-guidelines-for-software-and-artificial-intelligence-as-a-medical-device/ https://resource.ddregpharma.com/blogs/regulatory-guidelines-for-software-and-artificial-intelligence-as-a-medical-device/ https://resource.ddregpharma.com/blogs/regulatory-guidelines-for-software-and-artificial-intelligence-as-a-medical-device/ https://cdsco.gov.in/opencms/resources/uploadcdscoweb/2018/uploadtenderfile/corrigendum_to_cdsco_eoi_ssp_01st_dec.pdf https://cdsco.gov.in/opencms/resources/uploadcdscoweb/2018/uploadtenderfile/corrigendum_to_cdsco_eoi_ssp_01st_dec.pdf https://cdsco.gov.in/opencms/resources/uploadcdscoweb/2018/uploadtenderfile/corrigendum_to_cdsco_eoi_ssp_01st_dec.pdf	PERSON
globalce-210	409	2	https://www.ey.com/en_gl/insights/law/how-the-challenge-of-regulating-ai-in-healthcare-is-escalating https://www.ey.com/en_gl/insights/law/how-the-challenge-of-regulating-ai-in-healthcare-is-escalating	PERSON
globalce-210	409	3	https://doi.org/10.1001/jama.2019.21579	PRODUCT
globalce-210	410	1	https://www.fda.gov/medical-devices/digital-health-center-excellence/digital-health-software-precertification-pre-cert-pilot-program	CARDINAL